SurR9-C84A mutant nanocarrier and milk protein therapeutics for neurological disorders


Autoria(s): Sriramoju, Bhasker
Contribuinte(s)

Kanwar, Jagat R.

Kanwar, Rupinder

Data(s)

19/03/2014

Resumo

 The current project revealed that the novel nanoformulation of SurR9-C84A was able to rescue the neurons following the Alzheimer’s related ß-amyloid toxicity and inflammation. In addition, bovine lactoferrin was found to have potential differentiating effect in the tumor cells and hence is a valuable therapeutic for strengthening the degenerating neurons.

Identificador

http://hdl.handle.net/10536/DRO/DU:30067441

Idioma(s)

eng

Publicador

Deakin University, Faculty of Health, School of Medicine

Relação

http://dro.deakin.edu.au/eserv/DU:30067441/sriramoju-license-2014.pdf

http://dro.deakin.edu.au/eserv/DU:30067441/sriramoju-surR9-2014.pdf

Direitos

The author

Tipo

Thesis